Mechanistic studies revealed that compound 39 could inhibit FTO activity, increase the methylation levels of c-Myc and CEBPA mRNA, and reduce the stability of their transcripts, thereby suppressing related signals and inhibiting tumor progression. The gene discussed is MYC; the disease is neoplasm.